Temasek Holdings Private Ltd Increases Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Temasek Holdings significantly increased its UnitedHealth Group stake in the fourth quarter, boosting holdings by 531.4% to 222,874 shares worth about $73.6 million.
• Several analysts raised their price targets on UNH, and the stock now carries a Moderate Buy consensus rating with an average price target of $407.17.
• UnitedHealth reported better-than-expected quarterly earnings and revenue, and it also raised its quarterly dividend to $2.32 per share from $2.21.

Temasek Holdings Private Ltd boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 531.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 222,874 shares of the healthcare conglomerate's stock after purchasing an additional 187,574 shares during the quarter. Temasek Holdings Private Ltd's holdings in UnitedHealth Group were worth $73,573,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Sarver Vrooman Wealth Advisors purchased a new stake in UnitedHealth Group in the 4th quarter worth $25,000. Beacon Financial Strategies CORP purchased a new stake in UnitedHealth Group in the 4th quarter worth $26,000. Anfield Capital Management LLC raised its position in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after buying an additional 55 shares in the last quarter. Joseph Group Capital Management purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $27,000. Finally, Foster Dykema Cabot & Partners LLC raised its position in shares of UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on UNH shares. TD Cowen increased their price objective on shares of UnitedHealth Group from $311.00 to $337.00 and gave the stock a "hold" rating in a research report on Thursday, April 23rd. Mizuho increased their price objective on shares of UnitedHealth Group from $440.00 to $460.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $370.00 to $397.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 22nd. HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a research note on Wednesday, May 27th. Finally, Morgan Stanley upped their target price on shares of UnitedHealth Group from $395.00 to $453.00 and gave the stock an "overweight" rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $407.17.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company's stock, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.28% of the stock is owned by insiders.

UnitedHealth Group Price Performance

NYSE UNH opened at $411.32 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The firm's 50 day moving average price is $364.96 and its 200-day moving average price is $327.51. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $415.98. The company has a market cap of $373.54 billion, a PE ratio of 31.07, a P/E/G ratio of 1.64 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same period last year, the firm earned $7.20 earnings per share. The company's quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 15th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, June 15th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group's dividend payout ratio is currently 66.77%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.